Number of the records: 1
TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors
- 1.0191428 - UMG-J 20010500 RIV GB eng J - Journal Article
Plašilová, M. - Živný, J. - Jelínek, J. - Neuwirtová, R. - Čermák, J. - Nečas, E. - Anděra, Ladislav - Stopka, T.
TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors.
Leukemia. Roč. 16, č. 1 (2002), s. 67-73. ISSN 0887-6924. E-ISSN 1476-5551
R&D Projects: GA AV ČR IAA5052001; GA ČR GA301/99/0350
Institutional research plan: CEZ:AV0Z5052915
Keywords : TRAIL * leukemia * apoptosis
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 4.693, year: 2002
normal hematopoieticĺ progenitors and stem cells.#Lemfeld
Permanent Link: http://hdl.handle.net/11104/0087181
Number of the records: 1